FdaApplication
ANDA 202402
Identifiers
- fda_app_no: ANDA202402
Properties
| Property | Value |
|---|---|
| applicant_name | XGEN PHARMACEUTICALS DJB INC |
| application_type | ANDA |
| approval_date | 2016-03-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBUPROFEN LYSINE | IBUPROFEN LYSINE | EQ 20MG BASE/2ML (EQ 10MG BASE/ML) | INJECTABLE;INTRAVENOUS |
1 product